Cite
HARVARD Citation
Bossuyt, P. et al. (n.d.). OP40 Efficacy of risankizumab induction and maintenance therapy by baseline Crohn's Disease location: Post hoc analysis of the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies. Journal of Crohn's and colitis. p. i048. [Online].